Catalent Pharma Solutions Announces Major China Expansion With Two New Facilities for Softgel Technologies and Clinical Supply Solutions Businesses
3/11/2013 10:47:51 AM
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions, the global leader in drug development solutions and advanced delivery technologies for pharmaceutical, biologic and consumer health products, today announced two joint ventures in China for its Softgel Technologies and Clinical Supply Solutions businesses. Catalent continues to expand its global leadership by providing access to drug delivery and clinical trial capabilities for customers in Asia Pacific. The company intends to make additional investments in these two facilities over the next several years to broaden its offerings in the Chinese market.
comments powered by